Severe bone marrow suppression and hepatic dysfunction caused by piperacillin/tazobactam

Autor:	Xin-An Wu, Yan-Ping Wang, Zhong-Fang He
Rok vydání:	2013
Předmět:	Adult Male Microbiology (medical) medicine.medical_specialty Intracranial infection medicine.drug_class Antibiotics Penicillanic Acid Tazobactam Gastroenterology Bone Marrow Internal medicine Humans Medicine Adverse effect Piperacillin General Immunology and Microbiology business.industry Liver Diseases General Medicine Thrombocytopenia Piperacillin Tazobactam Drug Combination Infectious Diseases Liver Bone marrow suppression Piperacillin/tazobactam business Hepatic dysfunction Agranulocytosis medicine.drug
Zdroj:	Scandinavian Journal of Infectious Diseases. 45:885-887
ISSN:	1651-1980 0036-5548
DOI:	10.3109/00365548.2013.805426
Popis:	Piperacillin/tazobactam (TZP) is a commonly prescribed antibiotic. Here, we report a patient who developed agranulocytosis, thrombocytopenia, and severe hepatic dysfunction on day 17 while receiving TZP treatment for an intracranial infection. Bone marrow suppression and hepatic dysfunction are serious adverse effects that should be kept in mind when using long-term TZP.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90c73b563226d5382a1f04ed04a65fcf https://doi.org/10.3109/00365548.2013.805426 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.